Studies
-
Implementation
Current prescribing patterns for hypertension and atherosclerotic cardiovascular disease (ASCVD) in MSF programmes and their association with treatment outcomes and renal function: could there be a role for fixed dose combination drugs?
Principal investigator: Helen BygraveLatest update:Publication added by Holly Baker| 2nd August 2022